Impact News +++ Here′s Why Bionano Genomics Stock Jumped Today (Fool) +++ BIONANO GENOMICS Aktie -3,36%


 >NOVAVAX Aktienkurs 
105.86 EUR    -0.8%    (Tradegate)
Ask: 106.56 EUR / 46 Stück
Bid: 104.32 EUR / 47 Stück
Tagesumsatz: 6775 Stück
Realtime Kurs von 8 bis 22 Uhr!
>NOVAVAX Performance
1 Woche: +5,9%
1 Monat: +1,3%
3 Monate: +10,7%
6 Monate: +8,0%
1 Jahr: +2,0%
laufendes Jahr: +9,1%
Name:  NOVAVAX INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US6700024010 / A2PKMZ
Symbol/ Ticker:  NVV1 (Frankfurt)
Kürzel:  FRA:NVV1, NVV1.F, NVV1:GR
Index:  -
Marktkapitalisierung:  6320 Mio. EUR
Umsatz:  168.68 Mio. EUR
EBITDA:  -56.56 Mio. EUR
Gewinn je Aktie:  -4.663 EUR
Schulden:  375.45 Mio. EUR
Liquide Mittel:  415.21 Mio. EUR
Umsatz-/ Gewinnwachstum:  6,163.40% / -
KGV/ KGV lG:  - / 8.29
KUV/ KBV/ PEG:  30.29 / 77.05 / -
Gewinnm./ Eigenkapitalr.:  -133.10% / -468.16%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  NOVAVAX
Letzte Datenerhebung:  12.01.21
>NOVAVAX Eigentümer
Aktien: 63.66 Mio. St.
f.h. Aktien: 62.92 Mio. St.
Insider Eigner: 0.43%
Instit. Eigner: 50.57%
Leerverk. Aktien: -
>NOVAVAX Peer Group

16.01.21 - 00:48
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know (Zacks)
In the latest trading session, Novavax (NVAX) closed at $127.43, marking a -1.96% move from the previous day....
15.01.21 - 19:00
Novavax Hires Regulatory Expert As Coronavirus Vaccine Inches Closer To Emergency Use Filing (Benzinga)
Novavax, Inc. (NASDAQ: NVAX) is beefing up its executive team as it prepares to release results of its late-stage coronavirus vaccine study and file for emergency use authorization. read more...
15.01.21 - 14:03
Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer (GlobeNewswire EN)
GAITHERSBURG, Md., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Henrietta Ukwu, M.D., FACP...
15.01.21 - 12:42
Is Novavax′s Growth Story Over? (Fool)
The next few weeks could be critical for the biotech's coronavirus vaccine prospects....
15.01.21 - 12:18
Better Buy: Novavax vs. Moderna (Fool)
Both of these biotechs could be big winners in the COVID-19 vaccine market....
13.01.21 - 15:30
What′s Happening With Novavax Stock? (Forbes)
Vaccine developer Novavax (NASDAQ: NVAX) is seen as a key player in the Coronavirus vaccine space. Here's a quick overview of what has been happening with the company over the last few weeks. Firstly, Novavax initiated a phase 3 study for its Covid-...
13.01.21 - 00:42
Top bosses at drugs firm Novavax pocket £34m windfall as Covid-19 vaccine enters late-stage trials (DailyMail)
Novavax chief executive Stanley Erck and three of his colleagues offloaded the stock in a series of transactions since the start of 2020, capitalising on a near-3,000 per cent rise in the share price....
12.01.21 - 15:48
Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? (Zacks)
Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately....
12.01.21 - 15:48
Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax (Zacks)
Baxter's (BAX) BioPharma Solutions business inks deal to advance commercial-scale production and increase access for the COVID-19 vaccine in the U.K. and European markets....
12.01.21 - 14:57
South Korea nears deal to buy Novavax COVID-19 Vaccines - report (SeekingAlpha)
Um den gesamten Artikel unter zu lesen, klicken Sie bitte auf die Überschrift...
12.01.21 - 14:06
Baxter Biopharma inks sterile manufacturing services agreement for Novavax′ COVID-19 vaccine (SeekingAlpha)
Um den gesamten Artikel unter zu lesen, klicken Sie bitte auf die Überschrift...
12.01.21 - 01:42
Why Novavax Fell by Over 4% Today (Fool)
Investors seem perturbed by some reporting about top managers' recent financial moves....
12.01.21 - 00:09
Moderna Releases Details Of New Vaccine Deals While Novavax Moves To Phase 3 (Forbes)
Both companies stand to earn billions as their coronavirus vaccine programs move forward....
11.01.21 - 19:27
Novavax executives sold $46M worth company shares in 2020 – Reuters (SeekingAlpha)
Um den gesamten Artikel unter zu lesen, klicken Sie bitte auf die Überschrift...
11.01.21 - 18:31
BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year (MarketWatch)
Success would help Pfizer and BioNTech compete longer term with J&J and Novavax, whose vaccines don’t have the same temperature restrictions....
11.01.21 - 17:54
EU seeks more Moderna COVID-19 vaccines, eyes deals with Valneva, Novavax - Reuters (SeekingAlpha)
Um den gesamten Artikel unter zu lesen, klicken Sie bitte auf die Überschrift...
11.01.21 - 14:26
NOVAVAX INC: 8-K Report (SEC Filing)
FORM 8-K...
11.01.21 - 13:16
Novavax bosses cash out for $46 million with COVID-19 vaccine trials still under way (Reuters EN)
Top executives at U.S. pharmaceutical company Novavax Inc aren't waiting to see how well their COVID-19 vaccine works before they reap the financial rewards....
08.01.21 - 19:18
Novavax: Konkurrenz für BioNTech, AstraZeneca und Co. auf dem 5. Kontinent (4investors)
Um den gesamten Artikel unter zu lesen, klicken Sie bitte auf die Überschrift...
08.01.21 - 18:12
Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company′s Program Stand? (Benzinga)
Novavax, Inc. (NASDAQ: NVAX) shares are higher Friday following a coronavirus vaccine supply deal the company announced with the Australian government. read more...
>Zitat des Tages: Das Genie ist unter den andern Köpfen, was unter den Edelsteinen der Karfunkel: Er strahlt eigenes Licht aus, während die andern nur das empfangene reflektieren. - Arthur Schopenhauer
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ - Die Märkte im Blick!